• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片受体激活与阻断对头颈部鳞状细胞癌进展及治疗反应的影响

Effect of Opioid Receptor Activation and Blockage on the Progression and Response to Treatment of Head and Neck Squamous Cell Carcinoma.

作者信息

Levi Lirit, Hikri Elad, Popovtzer Aron, Dayan Avraham, Levi Amir, Bachar Gideon, Mizrachi Aviram, Shoffel-Havakuk Hagit

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Rabin Medical Center, Petach Tikva 49100, Israel.

Translational Research in Head and Neck Cancer, Felsenstein Medical Research Center, Rabin Medical Center, Tel Aviv University, Tel Aviv 6997801, Israel.

出版信息

J Clin Med. 2023 Feb 6;12(4):1277. doi: 10.3390/jcm12041277.

DOI:10.3390/jcm12041277
PMID:36835812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9967316/
Abstract

Recent studies suggest that opioids have a role in the progression of HNSCC mediated by mu opioid receptors (MOR), however, the effects of their activation or blockage remains unclear. Expression of MOR-1 was explored in seven HNSCC cell lines using Western blotting (WB). XTT cell proliferation and cell migration assays were performed on four selected cell lines (Cal-33, FaDu, HSC-2, and HSC-3), treated with opiate receptor agonist (morphine), antagonist (naloxone), alone and combined with cisplatin. All four selected cell lines display an increased cell proliferation and upregulation of MOR-1 when exposed to morphine. Furthermore, morphine promotes cell migration, while naloxone inhibits it. The effects on cell signaling pathways were analyzed using WB, demonstrating morphine activation of AKT and S6, key proteins in the PI3K/AKT/mTOR axis. A significant synergistic cytotoxic effect between cisplatin and naloxone in all cell lines is observed. In vivo studies of nude mice harboring HSC3 tumor treated with naloxone demonstrate a decrease in tumor volume. The synergistic cytotoxic effect between cisplatin and naloxone is observed in the in vivo studies as well. Our findings suggest that opioids may increase HNSCC cell proliferation via the activation of the PI3K/Akt/mTOR signaling pathway. Moreover, MOR blockage may chemo-sensitize HNSCC to cisplatin.

摘要

最近的研究表明,阿片类药物在由μ阿片受体(MOR)介导的头颈部鳞状细胞癌(HNSCC)进展中起作用,然而,其激活或阻断的效果仍不清楚。使用蛋白质印迹法(WB)在七种HNSCC细胞系中探究了MOR-1的表达。对四种选定的细胞系(Cal-33、FaDu、HSC-2和HSC-3)进行XTT细胞增殖和细胞迁移试验,这些细胞系分别用阿片受体激动剂(吗啡)、拮抗剂(纳洛酮)单独处理以及与顺铂联合处理。所有四种选定的细胞系在暴露于吗啡时均显示细胞增殖增加和MOR-1上调。此外,吗啡促进细胞迁移,而纳洛酮抑制细胞迁移。使用WB分析对细胞信号通路的影响,结果表明吗啡激活了PI3K/AKT/mTOR轴中的关键蛋白AKT和S6。在所有细胞系中均观察到顺铂和纳洛酮之间有显著的协同细胞毒性作用。对携带HSC3肿瘤的裸鼠进行纳洛酮体内研究,结果显示肿瘤体积减小。在体内研究中也观察到顺铂和纳洛酮之间的协同细胞毒性作用。我们的研究结果表明,阿片类药物可能通过激活PI3K/Akt/mTOR信号通路增加HNSCC细胞增殖。此外,MOR阻断可能使HNSCC对顺铂产生化疗敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/9e71f4826bc7/jcm-12-01277-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/ff2e9b14e332/jcm-12-01277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/7471c3827083/jcm-12-01277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/10d18fe0197b/jcm-12-01277-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/7977195ed411/jcm-12-01277-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/ac0527aa330d/jcm-12-01277-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/6cb9451c16b2/jcm-12-01277-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/9e71f4826bc7/jcm-12-01277-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/ff2e9b14e332/jcm-12-01277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/7471c3827083/jcm-12-01277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/10d18fe0197b/jcm-12-01277-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/7977195ed411/jcm-12-01277-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/ac0527aa330d/jcm-12-01277-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/6cb9451c16b2/jcm-12-01277-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81cf/9967316/9e71f4826bc7/jcm-12-01277-g007.jpg

相似文献

1
Effect of Opioid Receptor Activation and Blockage on the Progression and Response to Treatment of Head and Neck Squamous Cell Carcinoma.阿片受体激活与阻断对头颈部鳞状细胞癌进展及治疗反应的影响
J Clin Med. 2023 Feb 6;12(4):1277. doi: 10.3390/jcm12041277.
2
Mu-opioid receptor activation promotes in vitro and in vivo tumor growth in head and neck squamous cell carcinoma.μ 阿片受体激活促进头颈部鳞状细胞癌的体外和体内肿瘤生长。
Life Sci. 2021 Aug 1;278:119541. doi: 10.1016/j.lfs.2021.119541. Epub 2021 Apr 27.
3
DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.DKK3 敲低通过 PI3K/Akt 和 MAPK 信号通路对头颈部鳞状细胞癌细胞的恶性潜能产生负面影响。
Int J Oncol. 2019 Mar;54(3):1021-1032. doi: 10.3892/ijo.2018.4667. Epub 2018 Dec 14.
4
Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.阻断表皮生长因子受体通路抑制人头颈鳞癌细胞辐射诱导的迁移。
BMC Cancer. 2011 Sep 6;11:388. doi: 10.1186/1471-2407-11-388.
5
A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.一个涉及表皮生长因子受体/蛋白激酶B/哺乳动物雷帕霉素靶蛋白复合物1(EGFR/Akt/mTORC1)和IkB激酶/核因子-κB(IKK/NF-κB)的正反馈回路调节头颈部鳞状细胞癌的增殖。
Oncotarget. 2016 May 31;7(22):31892-906. doi: 10.18632/oncotarget.7441.
6
Silencing novel long non-coding RNA FKBP9P1 represses malignant progression and inhibits PI3K/AKT signaling of head and neck squamous cell carcinoma in vitro.沉默新型长非编码 RNA FKBP9P1 抑制头颈部鳞状细胞癌的恶性进展并抑制 PI3K/AKT 信号通路。
Chin Med J (Engl). 2020 Sep 5;133(17):2037-2043. doi: 10.1097/CM9.0000000000000933.
7
Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.转染 MORS196A 基因的 μ 阿片受体敲除小鼠中吗啡和纳洛酮的抗伤害作用。
J Biomed Sci. 2010 Apr 20;17(1):28. doi: 10.1186/1423-0127-17-28.
8
Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro.重组人促红细胞生成素在体外促进头颈部鳞状细胞癌细胞系恶性表型的获得。
BMC Res Notes. 2011 Dec 21;4:553. doi: 10.1186/1756-0500-4-553.
9
DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.DKK3 过表达增加头颈部鳞状细胞癌细胞的恶性特性。
Oncol Res. 2018 Jan 19;26(1):45-58. doi: 10.3727/096504017X14926874596386. Epub 2017 May 4.
10
Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.吗啡诱导非小细胞肺癌表皮生长因子通路激活。
Anesth Analg. 2011 Dec;113(6):1353-64. doi: 10.1213/ANE.0b013e318232b35a. Epub 2011 Oct 14.

引用本文的文献

1
Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade.右美托咪定诱导免疫原性癌细胞死亡并使肿瘤对程序性死亡受体1(PD-1)阻断敏感。
J Immunother Cancer. 2025 Jun 5;13(6):e010714. doi: 10.1136/jitc-2024-010714.
2
Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms.降低前列腺癌风险:频繁射精相关机制的作用
Cancers (Basel). 2025 Feb 28;17(5):843. doi: 10.3390/cancers17050843.
3
The Comparative Effect of Morphine on Proliferation of Cancer Cell Lines Originating from Different Organs: An In Vitro Study.

本文引用的文献

1
Mu-opioid receptor activation promotes in vitro and in vivo tumor growth in head and neck squamous cell carcinoma.μ 阿片受体激活促进头颈部鳞状细胞癌的体外和体内肿瘤生长。
Life Sci. 2021 Aug 1;278:119541. doi: 10.1016/j.lfs.2021.119541. Epub 2021 Apr 27.
2
Supraglottic Carcinoma in Intravenous Opioid Drug Abusers: A Distinct Disease with Improved Survival.静脉注射阿片类药物滥用者的声门上型癌:一种具有改善生存的独特疾病。
Laryngoscope. 2021 Apr;131(4):E1190-E1197. doi: 10.1002/lary.29067. Epub 2020 Sep 18.
3
Basic Opioid Pharmacology - An Update.
吗啡对源自不同器官的癌细胞系增殖的比较效应:一项体外研究。
Pharmaceuticals (Basel). 2024 Dec 9;17(12):1656. doi: 10.3390/ph17121656.
4
Impact of Surgical and Anesthetic Procedures after Colorectal Cancer Surgery: A Propensity Score-Matched Cohort Study (The PROCOL Study).结直肠癌手术后手术和麻醉程序的影响:倾向评分匹配队列研究(PROCOL 研究)。
Medicina (Kaunas). 2024 Aug 21;60(8):1362. doi: 10.3390/medicina60081362.
5
Opioids and Cancer: Current Understanding and Clinical Considerations.阿片类药物与癌症:当前认识与临床考量。
Curr Oncol. 2024 May 30;31(6):3086-3098. doi: 10.3390/curroncol31060235.
基础阿片类药物药理学——最新进展
Br J Pain. 2020 May;14(2):115-121. doi: 10.1177/2049463720911986. Epub 2020 Mar 20.
4
Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies.头颈部恶性肿瘤接受根治性放疗的癌症患者中阿片类药物长期使用的风险。
Oral Oncol. 2019 May;92:1-5. doi: 10.1016/j.oraloncology.2019.03.007. Epub 2019 Mar 12.
5
The μ-opioid receptor (MOR) promotes tumor initiation in hepatocellular carcinoma.μ-阿片受体(MOR)促进肝癌的肿瘤起始。
Cancer Lett. 2019 Jul 1;453:1-9. doi: 10.1016/j.canlet.2019.03.038. Epub 2019 Mar 27.
6
The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.μ 阿片受体是肝细胞癌预后不良的分子标志物,代表了一个潜在的治疗靶点。
Br J Anaesth. 2019 Jun;122(6):e157-e167. doi: 10.1016/j.bja.2018.09.030. Epub 2018 Dec 12.
7
Chronic opioid use in patients undergoing treatment for oropharyngeal cancer.接受口咽癌治疗的患者中慢性阿片类药物的使用情况。
Laryngoscope. 2019 Sep;129(9):2087-2093. doi: 10.1002/lary.27791. Epub 2019 Jan 6.
8
Morphine as a treatment of cancer-induced pain-is it safe? A review of in vivo studies and mechanisms.吗啡治疗癌痛是否安全?体内研究和机制的综述。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Nov;391(11):1169-1178. doi: 10.1007/s00210-018-1565-6. Epub 2018 Sep 20.
9
The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells.纳洛酮对人乳腺癌进展的影响:对MDA.MB231细胞的体外和体内研究
Onco Targets Ther. 2018 Jan 3;11:185-191. doi: 10.2147/OTT.S145780. eCollection 2018.
10
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.抑制 PI3K/Akt/mTOR 可克服三阴性乳腺癌细胞系 HCC38 对顺铂的耐药性。
BMC Cancer. 2017 Nov 3;17(1):711. doi: 10.1186/s12885-017-3695-5.